Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P R Clemens

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Gene Therapy|September 10, 2010
Effects of irradiating adult mdx mice before full-length dystrophin cDNA transfer on host anti-dystrophin immunityS Eghtesad, H Zheng, H Nakai, et al.
Nucleic Acids Research|September 11, 1991
Pentanucleotide repeat length polymorphism at the human CD4 locusM C Edwards, P R Clemens, M Tristan, et al.
Neurology|September 1, 1992
Premature chain termination mutation causing Duchenne muscular dystrophyP R Clemens, P A Ward, C T Caskey, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidaseS Kochanek, P R Clemens, K Mitani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Persistence in muscle of an adenoviral vector that lacks all viral genesH H Chen, L M Mack, R Kelly, et al.
Gene Therapy|October 16, 2004
Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in uteroR Bilbao, D P Reay, E Wu, et al.
Genomics|June 1, 1994
Linkage disequilibria among (CA)n polymorphisms in the human dystrophin gene and their implications in carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophiesR Chakraborty, Y Zhong, M de Andrade, et al.
Human Gene Therapy|February 27, 1999
DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscleH H Chen, L M Mack, S Y Choi, et al.
Human Gene Therapy|November 1, 1995
Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral deliveryP R Clemens, T L Krause, S Chan, et al.
Muscle & Nerve|May 22, 2001
Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in childrenD M Escolar, E K Henricson, J Mayhew, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Gene Therapy|September 10, 2010
Effects of irradiating adult mdx mice before full-length dystrophin cDNA transfer on host anti-dystrophin immunityS Eghtesad, H Zheng, H Nakai, et al.
Nucleic Acids Research|September 11, 1991
Pentanucleotide repeat length polymorphism at the human CD4 locusM C Edwards, P R Clemens, M Tristan, et al.
Neurology|September 1, 1992
Premature chain termination mutation causing Duchenne muscular dystrophyP R Clemens, P A Ward, C T Caskey, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidaseS Kochanek, P R Clemens, K Mitani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Persistence in muscle of an adenoviral vector that lacks all viral genesH H Chen, L M Mack, R Kelly, et al.
Gene Therapy|October 16, 2004
Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in uteroR Bilbao, D P Reay, E Wu, et al.
Genomics|June 1, 1994
Linkage disequilibria among (CA)n polymorphisms in the human dystrophin gene and their implications in carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophiesR Chakraborty, Y Zhong, M de Andrade, et al.
Human Gene Therapy|February 27, 1999
DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscleH H Chen, L M Mack, S Y Choi, et al.
Human Gene Therapy|November 1, 1995
Recombinant truncated dystrophin minigenes: construction, expression, and adenoviral deliveryP R Clemens, T L Krause, S Chan, et al.
Muscle & Nerve|May 22, 2001
Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in childrenD M Escolar, E K Henricson, J Mayhew, et al.
Pageof 4